ALD-301 for Critical Limb Ischemia, Randomized Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Critical Limb IschemiaPeripheral Arterial DiseasePeripheral Vascular Disease
Interventions
PROCEDURE

ALDH-br bone marrow cells vs. mononuclear bone marrow cells

Surgery

Trial Locations (5)

27710

Duke University Medical Center, Durham

30342

Saint Joseph's Research Institute, Atlanta

35211

Cardiology PC, Birmingham

46202

University of Indiana at Indianapolis, Indianapolis

77030

Texas Heart Institute, Stem Cell Center, 6770 Bertner, St Luke's Episcopal Hospital, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aldagen

INDUSTRY

NCT00392509 - ALD-301 for Critical Limb Ischemia, Randomized Trial | Biotech Hunter | Biotech Hunter